SNDX
Syndax Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$23.50
-0.49 ▼ -2.04%
🌙 3월 13일 5:59 PM ET (한국 3/14 06:59)
$23.70
+0.20 ▲ +0.85%
| Index | RUT | P/E | - | EPS (ttm) | -3.3 | Insider Own | 3.92% | Shs Outstand | 0.09B | Perf Week | 6.48% |
| Market Cap | 2.07B | Forward P/E | - | EPS next Y | 85.88% | Insider Trans | -0.86% | Shs Float | 0.08B | Perf Month | 8.25% |
| Enterprise Value | 2.02B | PEG | - | EPS next Q | -0.58 | Inst Own | 113.39% | Short Float | 25.72% | Perf Quarter | 13.97% |
| Income | -0.29B | P/S | 12.01 | EPS this Y | 51.75% | Inst Trans | -1.17% | Short Ratio | 16.63 | Perf Half Y | 43.56% |
| Sales | 0.17B | P/B | 31.78 | EPS next 5Y | - | ROA | -45.5% | Short Interest | 21.80M | Perf YTD | 11.85% |
| Book/sh | 0.74 | P/C | 5.26 | EPS past 3/5Y | -10.26% -12.05% | ROE | -161.82% | 52W High | -6.6% ($25.16) | Perf Year | 79.39% |
| Cash/sh | 4.47 | P/FCF | - | Sales past 3/5Y | - 157.68% | ROIC | -69.68% | 52W Low | 173.89% ($8.58) | Perf 3Y | 4.82% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 11.63% | Gross Margin | 95.96% | Volatility(W/M) | 6.42% 5.34% | Perf 5Y | 2.58% |
| Dividend TTM | - | EV/Sales | 11.73 | Sales Y/Y TTM | 628.88% | Oper. Margin | -158.08% | ATR (14) | 1.19 | Perf 10Y | 84.6% |
| Dividend Ex-Date | - | Quick Ratio | 4.12 | EPS Q/Q | 29.06% | Profit Margin | -165.37% | RSI (14) | 62.2 | Recom | 1.08 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.4 | Sales Q/Q | 794.9% | SMA20 | 8.36% ($21.69) | Beta | 0.42 | Target Price | $39.67 |
| Payout | - | Debt/Eq | 5.34 | Earnings | 2000000 | SMA50 | 10.81% ($21.21) | Rel Volume | 1.28 | Prev Close | $23.99 |
| Employees | 298 | LT Debt/Eq | 5.34 | EPS/Sales Surpr. | -33.56% 6.88% | SMA200 | 45.57% ($16.14) | Avg Volume(3M) | 1.31M | Price | $23.5 |
| IPO | 2016/3/3 | Option/Short | Yes/Yes | Trades | 13251 | Volume | 1,677,706 | Change | -2.04% |
뉴스 로딩 중...